The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Evaluation of the innate and adaptive immunity in type I and type II focal cortical dysplasias
Abstract
Summary: Purpose: Induction of inflammatory pathways has been reported in epileptic patients with focal malformations of cortical development. In the present study we examined the innate and adaptive immune responses in focal cortical dysplasia (FCD) with different histopathologic and pathogenetic features. Methods: The inflammatory cell components and the induction of major proinflammatory pathways and molecules [complement pathway, interleukin (IL)‐1β, and chemokine monocyte chemotactic protein‐1 (MCP1)] was investigated in surgical specimens of sporadic type IA and type IIB FCD using immunocytochemical methods. Results: FCD II but not FCD I cases exhibit activation of the mammalian target of rapamycin (mTOR) cascade with strong neuronal expression of the phosphorylated isoform of S6 protein. Microglia reactivity was increased in all lesions (FCD I and II) compared to control tissue; however, the number of HLA‐DR–positive cells was significantly higher in FCD II than in FCD I. In FCD II specimens we also observed perivascular and parenchymal T lymphocytes (CD3+), with a predominance of CD8+ T‐cytotoxic/suppressor lymphocytes, as well as a few dendritic cells. Expression of components of the complement cascade, IL‐1β, and MCP1 was prominent in FCD II cases. Discussion: Our findings indicate a prominent activation of both innate and adaptive immunity, with involvement of different inflammatory pathways in FCD II cases, supporting the possible involvement of inflammation in the epileptogenesis of these lesions, as well as the notion that FCD II is pathologically distinct from FCD I.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The role of inflammation in CNS injury and disease
Lucas, S., Rothwell, N. J., & Gibson, R. M. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706400 · Cited by 1,272 · cited 2×
“In particular the presence of the biologically active fragments of C3d indicates that the activation of the complement cascade has reached a point that may support a sustained inflammatory process [for review see (Lucas et al., 2006)].”
BackgroundGorter, J. A., van Vliet, E. A., Aronica, E., Breit, T., Rauwerda, H., Lopes da Silva, F. H., & Wadman, W. J. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.2766-06.2006 · Cited by 316
Self-citationMammalian target of rapamycin (mTOR) orchestrates the defense program of innate immune cells
Schmitz, F., Heit, A., Dreher, S., Eisenächer, K., Mages, J., Haas, T., Krug, A., Janssen, K., Kirschning, C. J., & Wagner, H. (2008) · European Journal of Immunology · doi:10.1002/eji.200838761 · Cited by 212
Glia as a source of cytokines: Implications for neuronal excitability and survival
Vezzani, A., Ravizza, T., Balosso, S., & Aronica, E. (2008) · Epilepsia · doi:10.1111/j.1528-1167.2008.01490.x · Cited by 197 · cited 14×
“Recent evidence strongly suggests the involvement of inflammatory processes in the etiopathogenesis of seizures (Vezzani & Granata, 2005; Vezzani et al., 2008).”
BackgroundInfluentialSelf-citationSerafini, B., Rosicarelli, B., Magliozzi, R., Stigliano, E., Capello, E., Mancardi, G. L., & Aloisi, F. (2006) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/65.2.124 · Cited by 176
Blümcke, I., Vinters, H. V., Armstrong, D., Aronica, E., Thom, M., & Spreafico, R. (2009) · Epileptic Disorders · doi:10.1684/epd.2009.0261 · Cited by 145
Self-citation
Cited by
The role of inflammation in epilepsy
Vezzani, A., French, J., Bartfai, T., & Baram, T. Z. (2011) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.178 · Cited by 1,876
Neuroinflammatory pathways as treatment targets and biomarkers in epilepsy
Vezzani, A., Balosso, S., & Ravizza, T. (2019) · Nature Reviews Neurology · doi:10.1038/s41582-019-0217-x · Cited by 893
Epilepsy and brain inflammation
Vezzani, A., Aronica, E., Mazarati, A., & Pittman, Q. J. (2013) · Experimental Neurology · doi:10.1016/j.expneurol.2011.09.033 · Cited by 603
Self-citationRasmussen's encephalitis: clinical features, pathobiology, and treatment advances
Varadkar, S., Bien, C. G., Kruse, C. A., Jensen, F. E., Bauer, J., Pardo, C. A., Vincent, A., Mathern, G. W., & Cross, J. H. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70260-6 · Cited by 479
Cytokines and brain excitability
Galic, M. A., Riazi, K., & Pittman, Q. J. (2012) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2011.12.002 · Cited by 446
Metadata
- Authors
- Iyer, A., Zurolo, E., Spliet, W. G. M., Van Rijen, P. C., Baayen, J. C., Gorter, J. A., & Aronica, E.
- Venue
- Epilepsia
- Publisher
- Wiley
- Published
- 2010-09
- Volume
- 51
- Issue
- 9
- Pages
- 1763-1773
- ISSN
- 0013-9580 (ISSN-L)
- 1528-1167
- OpenAlex
- W2150047376
- Cited by
- 178
- References
- 6
- FWCI
- 8.17
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Evaluation of the innate and adaptive immunity in type I and type II focal cortical dysplasias. https://app.cochat.ai/papers/10.1111/j.1528-1167.2010.02547.x
- The paper
- Iyer, A., Zurolo, E., Spliet, W. G. M., Van Rijen, P. C., Baayen, J. C., Gorter, J. A., & Aronica, E. (2010). Evaluation of the innate and adaptive immunity in type I and type II focal cortical dysplasias. Epilepsia. https://doi.org/10.1111/j.1528-1167.2010.02547.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.